Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Hepatitis B.World Health Organization, 2021https://www.who.int/news-room/fact-sheets/detail/hepatitis-bDate accessed: April 12, 2022
- Prevalence of HBsAg.https://cdafound.org/premium-dashboard/Date accessed: April 26, 2022
- Global perspective on hepatitis B virus infections in the era of effective vaccines.Clin Liver Dis. 2019; 23: 383-399
- Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.MMWR Recomm Rep. 2018; 67: 1-31
- Prevalence of chronic hepatitis B virus (HBV) infection in U.S. Households: National Health and Nutrition Examination survey (NHANES), 1988-2012.Hepatology. 2016; 63: 388-397
- An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States.Hepatology (Baltimore, Md). 2021; 74: 607-626
- Increases in acute hepatitis B virus infections - Kentucky, Tennessee, and West Virginia, 2006-2013.MMWR Morb Mortal Wkly Rep. 2016; 65: 47-50
- PreHevbrio for adult hepatitis B vaccination: evidence to recommendation and GRADE. Presented February 23, 2022.https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-02-23-24/02-HepWG-weng-508.pdfDate accessed: April 12, 2022
- Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant.MMWR Morb Mortal Wkly Rep. 2018; 67: 455-458
- PreHevbrio for adult hepatitis B vaccination evidence to recommendation and GRADE.https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-02-23-24/02-HepWG-weng-508.pdf2022Date accessed: April 12, 2022
- Global Health Sector Strategy on Viral Hepatitis 2016-2021. Updated May 17, 2016.https://www.who.int/publications/i/item/WHO-HIV-2016.06Date accessed: April 12, 2022
- General Best Practice Guidelines for Immunization.https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.htmlDate accessed: April 12, 2022
- Federal Register Notice for Hepatitis B Screening and Testing. CDC-2022-07050.https://www.cdc.gov/hepatitis/policy/isireview/HepBFederalRegisterNotice.htm2022. p. 19516-19617Date accessed: April 12, 2022
- AASLD guidelines for treatment of chronic hepatitis B.Hepatology. 2016; 63: 261-283
- EASL 2017 Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection.J Hepatol. 2017; 67: 370-398https://doi.org/10.1016/j.jhep.2017.03.021
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B Guidance.Hepatology (Baltimore, Md). 2018; 67: 1560-1599
- Asian-Pacific Clinical Practice Guidelines on the Management of Hepatitis B: a 2015 update.Hepatol Int. 2016; 10: 1-98
- Should treatment indications for chronic hepatitis B be expanded?.Clin Gastroenterol Hepatol. 2021; 19: 2006-2014
- Access to treatment for hepatitis B virus infection - worldwide, 2016.MMWR Morb Mortal Wkly Rep. 2018; 67: 773-777
- Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.Hepatology (Baltimore, Md). 2010; 51: 435-444
- Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.Gastroenterology. 2011; 141 (1248.e1-2): 1240-1248
- Extending treatment eligibility for chronic hepatitis B virus infection.Nat Rev Gastroenterol Hepatol. 2021; 18: 146-147
- Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels.Am J Gastroenterol. 2009; 104: 2206-2213
- A meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection.J Clin Pharmacol. 2015; 55: 288-297
- The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis.BMC Cancer. 2019; 19: 511
- New therapeutics for hepatitis B: the road to cure.Annu Rev Med. 2021; 72: 93-105
- Hepatitis B virus cure: targets and future therapies.Int J Mol Sci. 2020; 22https://doi.org/10.3390/ijms22010213
- Hepatitis D. Updated June 22, 2020.https://www.cdc.gov/hepatitis/hdv/index.htmDate accessed: April 16, 2022
- Natural history and treatment of chronic delta hepatitis.J Viral Hepat. 2010; 17: 749-756
- Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. an active and progressive disease unresponsive to immunosuppressive treatment.Ann Intern Med. 1983; 98: 437-441
- Devil hepatitis D: an orphan disease or largely underdiagnosed?.Gut. 2019; 68: 381-382
- Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection.J Iinfect Dis. 2020; 221: 1677-1687
- The global prevalence of hepatitis D virus infection: systematic review and meta-analysis.J Hepatol. 2020; 73: 523-532
- Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis.Gut. 2019; 68: 512-521
- Hepatitis D infection: from initial discovery to current investigational therapies.Gastroenterol Rep (Oxf). 2019; 7: 231-245
- Delta hepatitis within the Veterans Affairs Medical System in the United States: prevalence, risk factors, and outcomes.J Hepatol. 2015; 63: 586-592
- Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California.J Gastroenterol Hepatol. 2013; 28: 1521-1525
- Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.J Infect Dis. 2010; 202: 845-852
- Hepatitis D virus: a call to screening.Gastroenterol Hepatol (N Y). 2014; 10: 647-686
- Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011-2016.Clin Infect Dis. 2019; 69: 709-712
- Peginterferon plus adefovir versus either drug alone for hepatitis delta.N Engl J Med. 2011; 364: 322-331
- Treatment options for hepatitis delta virus infection.Curr Infect Dis Rep. 2013; 15: 31-38
Article info
Publication history
Published online: October 18, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
